| Dr Terry Evert Davenport, DO | |
|
229 S 8th St, St Maries, ID 83861-1813 | |
| (208) 245-2591 | |
| (208) 245-5246 |
| Full Name | Dr Terry Evert Davenport |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 33 Years |
| Location | 229 S 8th St, St Maries, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710974191 | NPI | - | NPPES |
| 601415700 | Other | DEEIOC | |
| S1303 | Other | ID | BLUE CROSS OF ID |
| 123363 | Other | WA | DEPT OF LABOR&INDUSTRIES |
| 8434839 | Medicaid | WA | |
| 805169900 | Medicaid | ID | |
| 000010004699 | Other | ID | REGENCE BS OF ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | O-130 (Idaho) | Secondary |
| 207Q00000X | Family Medicine | O-130 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hospice Of North Idaho | Hayden, ID | Hospice |
| Benewah Community Hospital | St maries, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Benewah Community Hospital | 1850200700 | 19 |
News Archive
Turning a vital component of cancer cells from bodyguard to assassin could form the basis of new cancer treatments, according to a report published this week.
Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
Coronary artery disease (CAD) is a leading cause of death worldwide. Despite dozens of regions in the genome associated with CAD, most of the genetic components of heart diseases are not fully understood, suggesting that more genes are out there to be found.
› Verified 2 days ago
| Entity Name | Benewah Community Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386632180 PECOS PAC ID: 1850200700 Enrollment ID: O20040927000265 |
News Archive
Turning a vital component of cancer cells from bodyguard to assassin could form the basis of new cancer treatments, according to a report published this week.
Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
Coronary artery disease (CAD) is a leading cause of death worldwide. Despite dozens of regions in the genome associated with CAD, most of the genetic components of heart diseases are not fully understood, suggesting that more genes are out there to be found.
› Verified 2 days ago
| Entity Name | Benewah Community Hospital |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1548320435 PECOS PAC ID: 1850200700 Enrollment ID: O20061104000136 |
News Archive
Turning a vital component of cancer cells from bodyguard to assassin could form the basis of new cancer treatments, according to a report published this week.
Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
Coronary artery disease (CAD) is a leading cause of death worldwide. Despite dozens of regions in the genome associated with CAD, most of the genetic components of heart diseases are not fully understood, suggesting that more genes are out there to be found.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Terry Evert Davenport, DO 229 S 8th St, St Maries, ID 83861-1813 Ph: (208) 245-2591 | Dr Terry Evert Davenport, DO 229 S 8th St, St Maries, ID 83861-1813 Ph: (208) 245-2591 |
News Archive
Turning a vital component of cancer cells from bodyguard to assassin could form the basis of new cancer treatments, according to a report published this week.
Transdel Pharmaceuticals, Inc. today announced that it will host a conference call and audio webcast on Tuesday, October 6, 2009 at 9:00 am, eastern, to announce the top-line results of its Phase 3 clinical study for Ketotransdel, a topical cream based non-steroidal anti-inflammatory drug ("NSAID") for acute pain.
DePuy Synthes, part of the Johnson & Johnson Family of Companies, today announced that implant survivorship data from the 2016 Australian Orthopaedic Association National Joint Replacement Registry (AOANJRR) confirm positive early results for DePuy Synthes' ATTUNE® Knee System. These data add to recent UK Joint Registry evidence which indicate that survivorship for the ATTUNE Knee compares favorably to other cemented knee systems in its class. In addition, recently-presented interim data on two studies suggest improved patient reported outcomes measures with the ATTUNE Knee compared to other leading knee systems.
Coronary artery disease (CAD) is a leading cause of death worldwide. Despite dozens of regions in the genome associated with CAD, most of the genetic components of heart diseases are not fully understood, suggesting that more genes are out there to be found.
› Verified 2 days ago
Karen D Libsch, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 229 S 8th St, St Maries, ID 83861 Phone: 208-245-2591 Fax: 208-245-5246 | |
Dr. Frederick Paul Ragan, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 229 S 7th St, St Maries, ID 83861 Phone: 208-245-7623 | |
Dr. Daniel Cooper Wester, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 229 S 7th St, St Maries, ID 83861 Phone: 208-245-5111 Fax: 208-245-9303 |